financetom
Business
financetom
/
Business
/
US targets Novo Nordisk's diabetes drug Ozempic for Medicare price talks
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
US targets Novo Nordisk's diabetes drug Ozempic for Medicare price talks
Jan 17, 2025 5:35 AM

WASHINGTON, Jan 17 (Reuters) - Novo Nordisk's

blockbuster diabetes drug Ozempic is among the 15 drugs targeted

for Medicare price negotiations for 2027, the U.S. government

said on Friday.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved